A. F. Kirkin, K. Dzhandzhugazyan, and J. Zeuthen, Melanoma-associated antigens recognized by cytotoxic T lymphocytes, APMIS, vol.106, pp.665-679, 1998.

R. F. Wang and S. A. Rosenberg, Human tumor antigens for cancer vaccine development, Immunol. Rev, vol.170, pp.85-100, 1999.

B. Lethe, S. Lucas, L. Michaux, S. C. De, D. Godelaine et al., LAGE-1, a new gene with tumor specificity, Int. J. Cancer, vol.76, pp.903-908, 1998.

Y. Guilloux, S. Lucas, V. G. Brichard, A. Van-pel, C. Viret et al., A peptide recognized by human cytolytic T lymphocytes on HLA-A2 melanomas is encoded by an intron sequence of the Nacetylglucosaminyltransferase V gene, J. Exp. Med, vol.183, pp.1173-1183, 1996.

A. Moreau-aubry, S. Le-guiner, N. Labarriere, M. C. Gesnel, F. Jotereau et al., A processed pseudogene codes for a new antigen recognized by a CD8(+) T cell clone on melanoma, J. Exp. Med, vol.191, pp.1617-1624, 2000.

R. Lupetti, P. Pisarra, A. Verrecchia, C. Farina, G. Nicolini et al., Translation of a retained intron in tyrosinase-related protein (TRP) 2 mRNA generates a new cytotoxic T lymphocyte (CTL)-defined and shared human melanoma antigen not expressed in normal cells of the melanocytic lineage, J. Exp. Med, vol.188, pp.1005-1016, 1998.

F. Salazar-onfray, T. Nakazawa, V. Chhajlani, M. Petersson, K. Karre et al., Synthetic peptides derived from the melanocyte-stimulating hormone receptor MC1R can stimulate HLA-A2-restricted cytotoxic T lymphocytes that recognize naturally processed peptides on human melanoma cells, Cancer Res, vol.57, pp.4348-4355, 1997.

Y. Kawakami, S. Eliyahu, C. Jennings, K. Sakaguchi, X. Kang et al., Recognition of multiple epitopes in the human melanoma antigen gp100 by tumor-infiltrating T lymphocytes associated with in vivo tumor regression, J. Immunol, vol.154, pp.3961-3968, 1995.

Y. Kawakami, N. Dang, X. Wang, J. Tupesis, P. F. Robbins et al., Recognition of shared melanoma antigens in association with major HLA-A alleles by tumor infiltrating T lymphocytes from 123 patients with melanoma, J. Immunother, vol.23, pp.17-27, 2000.

N. Labarriere, M. C. Pandolfino, D. Raingeard, S. Le-guiner, E. Diez et al., Frequency and relative fraction of tumor antigen-specific T cells among lymphocytes from melanoma-invaded lymph nodes, Int. J. Cancer, vol.78, pp.209-215, 1998.

E. De-plaen, C. Lurquin, B. Lethe, P. Van-der-bruggen, V. Brichard et al., Identification of genes coding for tumor antigens recognized by cytolytic T lymphocytes, vol.12, pp.125-142, 1997.

E. Scotet, J. David-ameline, M. A. Peyrat, A. Moreau-aubry, D. Pinczon et al., T cell response to Epstein-Barr virus transactivators in chronic rheumatoid arthritis, J. Exp. Med, vol.184, pp.1791-1800, 1996.

D. J. Loftus, C. Castelli, T. M. Clay, P. Squarcina, F. M. Marincola et al., Identification of epitope mimics recognized by CTL reactive to the melanoma/melanocyte-derived peptide MART, pp.27-35

, J. Exp. Med, vol.184, pp.647-657, 1996.

M. L. Salgaller, A. Afshar, F. M. Marincola, L. Rivoltini, Y. Kawakami et al., Recognition of multiple epitopes in the human melanoma antigen gp100 by peripheral blood lymphocytes stimulated in vitro with synthetic peptides, Cancer Res, vol.55, pp.4972-4979, 1995.

Y. Kawakami, P. F. Robbins, X. Wang, J. P. Tupesis, M. R. Parkhurst et al., Identification of new melanoma epitopes on melanosomal proteins recognized by tumor infiltrating T lymphocytes restricted by HLA-A1, -A2, and -A3 alleles, J. Immunol, vol.161, pp.6985-6992, 1998.

I. Kawashima, V. Tsai, S. Southwood, K. Takesako, E. Celis et al., Identification of gp100-derived, melanomaspecific cytotoxic T-lymphocyte epitopes restricted by HLA-A3 supertype molecules by primary in vitro immunization with peptide-pulsed dendritic cells, Int. J. Cancer, vol.78, pp.518-524, 1998.

V. Tsai, S. Southwood, J. Sidney, K. Sakaguchi, Y. Kawakami et al., Identification of subdominant CTL epitopes of the GP100 melanoma-associated tumor antigen by primary in vitro immunization with peptide-pulsed dendritic cells, J. Immunol, vol.158, pp.1796-1802, 1997.

A. L. Cox, J. Skipper, Y. Chen, R. A. Henderson, T. L. Darrow et al., Identification of a peptide recognized by five melanoma-specific human cytotoxic T cell lines, Science, vol.264, pp.716-719, 1994.

C. Castelli, P. Tarsini, A. Mazzocchi, F. Rini, L. Rivoltini et al., Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigens, J. Immunol, vol.162, pp.1739-1748, 1999.

V. Brichard, P. A. Van, T. Wolfel, C. Wolfel, P. E. De et al., The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas, J. Exp. Med, vol.178, pp.489-495, 1993.

V. G. Brichard, J. Herman, P. A. Van, C. Wildmann, B. Gaugler et al., A tyrosinase nonapeptide presented by HLA-B44 is recognized on a human melanoma by autologous cytolytic T lymphocytes, Eur. J. Immunol, vol.26, pp.224-230, 1996.

S. Morel, A. Ooms, A. Van-pel, T. Wolfel, V. G. Brichard et al., A tyrosinase peptide presented by HLA-B35 is recognized on a human melanoma by autologous cytotoxic T lymphocytes, Int. J. Cancer, vol.83, pp.755-759, 1999.

E. Zorn and T. Hercend, A MAGE-6-encoded peptide is recognized by expanded lymphocytes infiltrating a spontaneously regressing human primary melanoma lesion, Eur. J. Immunol, vol.29, pp.602-607, 1999.

M. C. Panelli, M. P. Bettinotti, K. Lally, G. A. Ohnmacht, Y. Li et al., A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12, J. Immunol, vol.164, pp.4382-4392, 2000.

P. G. Coulie, V. Brichard, and A. Van-pel, A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas, J. Exp. Med, vol.180, pp.35-42, 1994.

N. Labarriere, E. Diez, M. C. Pandolfino, C. Viret, Y. Guilloux et al., Optimal T cell activation by melanoma cells depends on a minimal level of antigen transcription, J. Immunol, vol.158, pp.1238-1245, 1997.
URL : https://hal.archives-ouvertes.fr/inserm-02482164